title: Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?
authors.affiliation: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
authors.forename: Jyh-Ming
authors.initials: JM
authors.lastname: Liou
authors.affiliation: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei and College of Medicine, Fu-Ren Catholic University and Big Data Research Centre, Fu-Ren Catholic University, New Taipei City, Taiwan.
authors.forename: Jaw-Town
authors.initials: JT
authors.lastname: Lin
authors.affiliation: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
authors.forename: Ming-Shiang
authors.initials: MS
authors.lastname: Wu
mesh_terms: D000658:Amoxicillin; D000863:Antacids; D000900:Anti-Bacterial Agents; D000930:Antidiarrheals; D001729:Bismuth; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections; D016480:Helicobacter pylori; D006801:Humans; D008795:Metronidazole; D016896:Treatment Outcome
chemical_list: D000863:Antacids; D000900:Anti-Bacterial Agents; D000930:Antidiarrheals; D008795:Metronidazole; D000658:Amoxicillin; D001729:Bismuth